
GC73944
SE-7552
Also known as 5-[5-(difluoromethyl)-1,3,4-oxadiazol-2-yl]-N-[1-(4-fluorophenyl)ethyl]pyrimidin-2-amine
SE-7552, a 2-(difluorometl)-1,3,4-oxadiazole (DFMO) derivative, is an orally active, highly selective, non-droxamate HDAC6 inhibitor with an IC50 of 33 nM
ChemicalCAS2243575-79-1MW335.28FormulaC15H12F3N5O
- CAS number
- 2243575-79-1
- Molecular weight
- 335.28
- Formula
- C15H12F3N5O
- Solubility
- DMSO : 100 mg/mL (298·26 mM; Need ultrasonic)
- InChIKey
- JVVZKJQCRUTIMB-UHFFFAOYSA-N
- Catalogue number
- GC73944
- Brand
- GLPBIO
Computed properties PubChem CID 135320929 · XLogP 2.7 · TPSA 76.7 Ų · H-bond donors 1
- XLogP
- 2.7
- TPSA
- 76.7 Ų
- H-bond donors
- 1
- H-bond acceptors
- 9
- Rotatable bonds
- 5
- Heavy atoms
- 24
SMILES CC(C1=CC=C(C=C1)F)NC2=NC=C(C=N2)C3=NN=C(O3)C(F)F
Computed descriptors from PubChem (CID 135320929), public domain. Identity cross-checked against the supplier's molecular formula and weight — verify before use.
Ordering in Israel
- Lead time
- Ships from the manufacturer to your lab in 8–14 business days; customs and cold chain handled by LABO Scientific.
- Pricing
- Quoted in ILS, excl. VAT. Add the item to your quote and we confirm the final price, usually the same business day.
- Documents
- Lot certificate of analysis and manufacturer SDS are emailed with your order confirmation.
- Who we serve
- Universities, hospitals and biotech companies across Israel. Research use only — not for diagnostic or therapeutic use.
- Questions
- WhatsApp · +972-55-990-7576 · orders@labo.co.il